Assenagon Asset Management S.A. Regeneron Pharmaceuticals, Inc. Transaction History

Assenagon Asset Management S.A.

$65.1 Billion
Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 477,810 shares of REGN stock, worth $313 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

477,810

Previous 423,325 12.87%

Holding current value

$313 Million

Previous $222 Million 20.88%

% of portfolio

0.41%

Previous 0.37%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$534.91 - $598.71 $29.1 Million - $32.6 Million	54,485 Added 12.87%	477,810 $269 Million
Q2 2025 Jul 11, 2025	SELL	$483.07 - $625.6 $28 Million - $36.3 Million	-58,064 Reduced 12.06%	423,325 $222 Million
Q1 2025 Apr 15, 2025	BUY	$634.14 - $744.83 $193 Million - $226 Million	303,785 Added 171.05%	481,389 $305 Million
Q4 2024 Jan 14, 2025	BUY	$701.85 - $1046.91 $3.33 Million - $4.97 Million	4,745 Added 2.75%	177,604 $127 Million
Q3 2024 Oct 23, 2024	BUY	$1024.09 - $1201.76 $45.5 Million - $53.4 Million	44,457 Added 34.62%	172,859 $182 Million
Q2 2024 Jul 18, 2024	SELL	$883.2 - $1071.19 $54.1 Million - $65.6 Million	-61,283 Reduced 32.31%	128,402 $135 Million
Q1 2024 Apr 24, 2024	SELL	$902.69 - $993.35 $24.2 Million - $26.7 Million	-26,838 Reduced 12.39%	189,685 $183 Million
Q4 2023 Jan 17, 2024	BUY	$775.18 - $881.7 $94.7 Million - $108 Million	122,103 Added 129.32%	216,523 $190 Million
Q3 2023 Nov 06, 2023	SELL	$692.45 - $844.37 $16.5 Million - $20.2 Million	-23,865 Reduced 20.18%	94,420 $77.7 Million
Q2 2023 Jul 25, 2023	SELL	$700.03 - $830.35 $59.5 Million - $70.6 Million	-84,982 Reduced 41.81%	118,285 $85 Million
Q1 2023 Apr 18, 2023	BUY	$680.49 - $826.97 $55.3 Million - $67.2 Million	81,231 Added 66.56%	203,267 $167 Million
Q4 2022 Jan 12, 2023	BUY	$705.89 - $766.39 $27.6 Million - $29.9 Million	39,065 Added 47.08%	122,036 $88 Million
Q3 2022 Oct 27, 2022	BUY	$573.97 - $724.32 $7.3 Million - $9.21 Million	12,715 Added 18.1%	82,971 $57.2 Million
Q2 2022 Jul 27, 2022	BUY	$548.35 - $738.84 $2.6 Million - $3.5 Million	4,735 Added 7.23%	70,256 $41.5 Million
Q1 2022 Apr 25, 2022	BUY	$595.12 - $698.43 $21 Million - $24.7 Million	35,303 Added 116.83%	65,521 $45.8 Million
Q4 2021 Feb 01, 2022	SELL	$543.48 - $670.97 $5.53 Million - $6.83 Million	-10,179 Reduced 25.2%	30,218 $19.1 Million
Q3 2021 Oct 19, 2021	BUY	$574.03 - $680.96 $18 Million - $21.3 Million	31,315 Added 344.8%	40,397 $24.4 Million
Q2 2021 Jul 15, 2021	SELL	$472.8 - $558.54 $86.3 Million - $102 Million	-182,599 Reduced 95.26%	9,082 $5.07 Million
Q1 2021 Apr 26, 2021	BUY	$446.73 - $548.2 $15.8 Million - $19.4 Million	35,429 Added 22.67%	191,681 $90.7 Million
Q4 2020 Feb 01, 2021	BUY	$478.3 - $607.98 $74.7 Million - $95 Million	156,252 New	156,252 $75.5 Million
Q3 2020 Oct 07, 2020	SELL	$544.75 - $658.21 $18.9 Million - $22.8 Million	-34,668 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$493.32 - $643.92 $16.5 Million - $21.5 Million	33,409 Added 2653.61%	34,668 $21.6 Million
Q1 2020 Apr 17, 2020	SELL	$336.18 - $494.43 $9.09 Million - $13.4 Million	-27,029 Reduced 95.55%	1,259 $615,000
Q4 2019 Jan 17, 2020	SELL	$274.13 - $376.51 $1.61 Million - $2.21 Million	-5,878 Reduced 17.2%	28,288 $10.6 Million
Q3 2019 Oct 16, 2019	SELL	$273.46 - $318.39 $18.4 Million - $21.5 Million	-67,419 Reduced 66.37%	34,166 $9.48 Million
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $1.13 Million - $1.56 Million	3,768 Added 3.85%	101,585 $31.8 Million
Q1 2019 Apr 26, 2019	BUY	$372.08 - $439.57 $23.1 Million - $27.3 Million	62,022 Added 173.27%	97,817 $40.2 Million
Q4 2018 Jan 23, 2019	SELL	$335.82 - $403.04 $25.1 Million - $30.1 Million	-74,776 Reduced 67.63%	35,795 $13.4 Million
Q3 2018 Oct 29, 2018	SELL	$351.14 - $408.51 $1.17 Million - $1.36 Million	-3,330 Reduced 2.92%	110,571 $44.7 Million
Q2 2018 Jul 17, 2018	BUY	$284.6 - $344.99 $19.5 Million - $23.7 Million	68,562 Added 151.22%	113,901 $39.3 Million
Q1 2018 Apr 30, 2018	BUY	$315.82 - $393.78 $2.17 Million - $2.71 Million	6,880 Added 17.89%	45,339 $15.6 Million
Q4 2017 Jan 25, 2018	SELL	$358.63 - $469.95 $30 Million - $39.2 Million	-83,515 Reduced 68.47%	38,459 $14.5 Million
Q3 2017 Oct 18, 2017	BUY	$431.38 - $504.0 $52.6 Million - $61.5 Million	121,974	121,974 $54.5 Million

Others Institutions Holding REGN

# of Institutions

1,437

Shares Held

88.9M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $70.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Regeneron Pharmaceuticals, Inc. Transaction History